Publications

5674 Results

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events

Authors
SM Lee;J Miao;JM Unger;K Cheung;DL Hershman
Journal / Conference
Health and Quality of Life Outcomes Aug 22;17(1):146
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID31438967
PMC
PMC6704545
Study Number(s)
S9916

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

Authors
T Synold;M Plets;C Tangen;E Heath;G Palapattu;P Mack;M Stein;M Meng;P Lara;N Vogelzang;IM Thompson;CR Ryan
Journal / Conference
Kidney Cancer Aug 7;3(2):111-118
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID31763512
PMC
PMC6864417
Study Number(s)
S0931

The accuracy of clinical staging of stage I-III non-small cell lung cancer: An analysis based on individual participant data [on behalf of the NSCLC Meta-analysis Collaborative Group (K Kelly)]

Authors
N Navani;D Fisher;J Tierney;S Burdett;SWOG Collaborators:;PA Bunn;E Vallieres
Journal / Conference
Chest Mar;155(3):502-509
Year
2019
Research Committee(s)
Lung
PMID
PMID30391190
PMC
PMC6435782
Study Number(s)
S9900

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

Authors
G Abou-Alfa;Q Shi;J Knox;A Kaubisch;D Niedzwiecki;J Posey;B Tan;P Kavan;R Goel;P Lammers;T Bekaii-Saab;VC Tam;L Rajdev;R Kelley;A El-Khoueiry;I El Dika;T Zemla;R Potaracke;J Balletti;L Schwartz;RM Goldberg;M Bertagnolli;J Meyerhardt;E O'Reilly;A Venook
Journal / Conference
JAMA Oncology Sep 5;5(11):1582-1588; Sep 5;. doi: 10.1001/jamaoncol.2019.2792. [Epub ahead of print]
Year
2019
Research Committee(s)
Gastrointestinal
PMID
PMID31486832
PMC
PMC6735405
Study Number(s)
CTSU/C80802

Associations of Physical Activity with Survival and Progression in Metastatic Colorectal Cancer: Results from CALGB(Alliance)/SWOG 80405

Authors
B Guercio;S Zhang;F-S Ou;A Venook;D Niedzwiecki;H-J Lenz;F Innocenti;B O'Neil;JE Shaw;B Polite;H Hochster;J Atkins;R Goldberg;K Sato;K Ng;E Van Blarigan;RJ Mayer;CD Blanke;E O'Reilly;C Fuchs;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology Oct 10;37(29):2620-2631
Year
2019
Research Committee(s)
Gastrointestinal
PMID
PMID31408415
PMC
PMC6900834
Study Number(s)
CTSU/C80405

5a-Reductase Inhibitor Use in Patients With Prostate Cancer [Letter to the Editor/Comment & Response] re: Sarkar RR, Parsons JK, Bryant AK, et al.]

Authors
IM Thompson;CM Tangen;B Kramer
Journal / Conference
JAMA Internal Medicine Oct 1;179(10):1440
Year
2019
Research Committee(s)
Cancer Control
PMID
PMID31589258
Study Number(s)
SWOG-9217

Adjuvant Chemotherapy with Standard Regimens versus Capecitabine in Older Women with Early Stage Breast Cancer: 10-year update of Alliance/CALGB trial 49907

Authors
H Muss;M Polley;DA Berry;H Liu;C Cirrincione;M Theodoulou;A Mauer;A Kornblith;A Partridge;LG Dressler;HJ Cohen;H Becker;P Kartcheske;J Wheeler;EA Perez;A Wolff;J Gralow;H Burstein;AA Mahmood;G Magrinat;BA Parker;RD Hart;D Grenier;Arti Hurria;L Norton;C Hudis;E Winer;L Carey
Journal / Conference
Journal of Clinical Oncology Sep 10;37(26):2338-2348. doi: 10.1200/JCO.19.00647. Epub 2019 Jul 24.
Year
2019
Research Committee(s)
Breast
PMID
PMID31339827
PMC
PMC6900836

Prevalence of drug-drug interactions in oncology patients enrolled in two completed SWOG clinical trials

Authors
L Marcath;C Finley;S-F Wong;D Hertz
Journal / Conference
American College of Clinical Pharmacology (9/15-17/2019, Chicago, IL), poster
Year
2019
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S0528, S0711

Validation of the DNA Damage Immune Response (DDIR) Signature in Triple-Negative Breast Cancer (TNBC) Patients from the SWOG 9313c Trial

Authors
P Sharma;W Barlow;A Godwin;E Parkes;L Knight;SM Walker;RD Kennedy;D Harkin;G Logan;CJ Steele;S Lambe;S Badve;Y Gokmen-Polar;H Pathak;K Isakova;HM Linden;P Porter;L Pusztai;AM Thompson;D Tripathy;G Hortobagyi;D Hayes
Journal / Conference
Journal of Clinical Oncology Dec 20;37(36):3484-3492; Oct 28[Online ahead of print]
Year
2019
Research Committee(s)
Breast
PMID
PMID31657982
PMC
PMC7194448
Study Number(s)
SWOG-9313

Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the NCCTG N9831 (Alliance) Study

Authors
C Thorpe;C Vargas;A Dueck;K Tenner;E Perez;ES Hwang;M Halyard;T Pisansky;S Martino;N Davidson;B Pockaj
Journal / Conference
ASTRO Annual Meeting (9/15-18/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Breast
Study Number(s)
N9831